APPLICATION
ANDA065009
TYPE
ANDA
ORIGINAL APPROVAL
2002-03-18
LATEST ACTION
2004-03-17
ROUTE
TOPICAL
DOSAGE FORM
GEL
MARKETING STATUS
Discontinued
Products
E-GLADESDiscontinued
ERYTHROMYCIN 2% · GEL · TOPICAL
Approval history
2004-03-17Labeling · Supplement 4AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.